Searched for
PRESCRIPTION DRUG COSTS
Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...06 Aug, 2026, 01.04 PM IST
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...04 Aug, 2026, 11.04 AM IST
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...31 Jul, 2026, 01.42 AM IST
- Why are Health Systems walking away from Medicare Advantage contracts in 2026? Here’s what enrolled Americans really need to knowTwenty-five hospital systems will end Medicare Advantage contracts in 2026. This move risks patient access to doctors and hospitals startin...30 Jul, 2026, 01.19 PM IST
- Trump administration to end Medicare Part D subsidy after 2026The Trump administration will end a Medicare Part D subsidy program after 2026. Insurers have gained enough experience to price plans accur...29 Jul, 2026, 09.15 AM IST
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...26 Jul, 2026, 02.45 PM IST
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...23 Jul, 2026, 10.16 AM IST
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...22 Jul, 2026, 01.58 PM IST
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...22 Jul, 2026, 01.32 PM IST
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...22 Jul, 2026, 01.13 PM IST
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...22 Jul, 2026, 12.48 PM IST
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...22 Jul, 2026, 12.42 PM IST
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...22 Jul, 2026, 12.30 PM IST
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...22 Jul, 2026, 11.27 AM IST
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...22 Jul, 2026, 09.40 AM IST
- Woman develops rare life-threatening skin disorder after taking painkiller: Doctor ordered to pay Rs 5.5 lakh compensationA Raipur consumer commission has ordered a neurologist to pay Rs 5.5 lakh to a woman who developed Stevens-Johnson Syndrome, a rare and lif...20 Jul, 2026, 11.30 AM IST
Load More
